Scientific papers

Respiratory complex I regulates dendritic cell maturation in explant model of human tumor immune microenvironment

Published Sep. 17, 2024 5:13 PM

Tutorial on survival modeling with applications to omics data

Published Sep. 17, 2024 5:12 PM

Multivariate Bayesian structured variable selection for pharmacogenomic studies

Published Sep. 17, 2024 5:11 PM

BreastScreen Norway discusses how the results from their screening programme for early breast cancer detection can influence future artificial intelligence (AI) to streamline early breast cancer detection/RESCUER

Published Sep. 17, 2024 5:09 PM

Artificial intelligence (AI) tools in genetics - RESCUER

Published Sep. 17, 2024 5:05 PM

Digital Life Norway (DLN) Initiative to foster and boost transdisciplinary biotechnology research and innovation

Published Sep. 17, 2024 5:04 PM

The breast cancer coagulome in the tumor microenvironment and its role in prognosis and treatment response to chemotherapy.

Published Sep. 17, 2024 5:02 PM

An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer.

Published Sep. 17, 2024 4:58 PM

Copy number alterations: a catastrophic orchestration of the breast cancer genome.

Published Sep. 17, 2024 4:58 PM

Clinical course of ulcerative colitis: Frequent use of biologics and low colectomy rate first year after diagnosis-results from the IBSEN III inception cohort.

Published Sep. 17, 2024 4:55 PM

Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes.

Published Sep. 17, 2024 4:53 PM

The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancer.

Published Sep. 17, 2024 4:52 PM

CD4+ T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy

Published Sep. 17, 2024 4:50 PM

Modeling of Mouse Experiments Suggests that Optimal Anti-Hormonal Treatment for Breast Cancer is Diet-Dependent

Published Sep. 17, 2024 4:49 PM

Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer

Published Sep. 17, 2024 4:48 PM

Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response

Published Sep. 17, 2024 4:47 PM

Unraveling the clinicopathological and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-low and HER2-0 breast cancer

Published Sep. 17, 2024 4:46 PM

Computational Model Predicts Patient Outcomes in Luminal B Breast Cancer Treated with Endocrine Therapy and CDK4/6 Inhibition

Published Sep. 17, 2024 4:45 PM

Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy

Published Sep. 17, 2024 4:44 PM

A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies

Published Sep. 17, 2024 4:43 PM

Intrinsic Subtype and Overall Survival of Patients with Advanced HR+/HER2− Breast Cancer Treated with Ribociclib and ET: Correlative Analysis of MONALEESA-2, -3, -7

Published Sep. 17, 2024 4:41 PM

Obesity-associated changes in molecular biology of primary breast cancer

Published Sep. 17, 2024 4:40 PM

RESCUER: Supporting new concepts for breast cancer subtypes treatment

Published Sep. 17, 2024 4:30 PM

Transcriptomic pan-cancer analysis using rank-based Bayesian inference.

Published Sep. 17, 2024 4:29 PM

High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer.

Published Sep. 17, 2024 4:28 PM